Laprovet

What Laprovet does

LAPROVET SAS is a French veterinary pharmaceutical company founded in 1980 and headquartered in Notre Dame d'Oé (Tours), France, with a manufacturing subsidiary in Hungary dedicated to avian vaccine production. The company manufactures and distributes a comprehensive portfolio of animal health products across four segments: industrial poultry (live AVI vaccines, inactivated ITA vaccines, disinfectants, internal parasiticides, anticoccidials, and anti-infectives formulated for solubility in drinking water), traditional/village poultry (the ITA-NEW inactivated Newcastle disease vaccine in 100-dose PET vials adapted for rural farming, plus the V.P.V. polyvalent dewormer), ruminants (trypanocidals SECURIDIUM and SURVIDIM, external parasiticide CYPERTOP, internal parasiticides BENZAL/BOLUMISOLE/DITROX, and anti-infectives OXYCLINE 20%/PENI-STREPTO/VETOSPRAY), and companion animals (vaccines, antiparasitic tablets, nutritional complements, insecticidal shampoo). All products are manufactured in European GMP-certified facilities meeting GMP, GDP, and GLP standards.

The company operates a distributor-led go-to-market model through a network of authorized distributors covering more than 40 countries across five geographical regions (Asia, Europe, Middle East, Africa, and the Indian Ocean), supported by approximately 20 field representatives who provide technical training to professional livestock farming sectors. Laprovet holds 36 Community Marketing Authorizations (AMM) in the UEMOA zone — the largest number among veterinary companies in West Africa — and is positioned as the leader in Animal Health in Sub-Saharan Africa. Distribution is gated by per-market Marketing Authorization requirements, and the company develops target-market-specific packaging (e.g., 100-dose village poultry vials) through partnerships with international development organizations such as CPAVI and Vétérinaires sans Frontières.

Commercial revenue is generated through one-time sale of veterinary medicinal products rather than recurring licenses or subscription models. Pricing is not publicly disclosed. The company is privately held as a SAS (Société par Actions Simplifiée) with capital of €800,450, led by Managing Director Guillaume Remond, operating without disclosed institutional investors, parent companies, or public funding rounds. Marketing channels include VIV international trade shows (Utrecht, Bangkok), social media presence launched in 2018 (Facebook, LinkedIn, Twitter), and educational content such as poultry farming guides. The company was recognized with the 'Top des Entreprises' award from La Nouvelle République in 2014.

Name

Laprovet

Legal name

LAPROVET SAS

Website

https://laprovet.com

Company type

Private

Founded year

1980

Operating status

Operating

Headcount range

11–50 employees

Short description

Laprovet is a French veterinary pharmaceutical company that manufactures GMP-certified animal health products — vaccines, parasiticides, anti-infectives — for livestock and companion animals, distributing them through authorized networks across 40+ countries with a leadership position in Sub-Saharan Africa.

Ownership category

akta.pro rank

Headquarters

HQ city

Notre-dame-d'oe

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Veterinary Pharmaceuticals: Sale of veterinary medicinal products including vaccines, trypanocidals, parasiticides, disinfectants, and anti-infectives for poultry, ruminants, and pets. Products are distributed through authorized distributor networks and direct field sales. Manufacturing in GMP-certified European facilities.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Core offering

Laprovet manufactures and sells veterinary pharmaceuticals for livestock and companion animals, organized into four product ranges: industrial poultry (live and inactivated vaccines, disinfectants, parasiticides, anticoccidials, anti-infectives), traditional/village poultry (ITA-NEW Newcastle disease vaccine and V.P.V. polyvalent dewormer in adapted packaging), ruminants (trypanocidals such as SECURIDIUM and SURVIDIM, external and internal parasiticides, anti-infectives), and pets (vaccines, antiparasitics, nutritional complements, insecticidal shampoo). Products are produced in GMP-certified European facilities and distributed via authorized distributors to professional farming sectors in more than 40 countries.

Product overview

Laprovet is a French veterinary pharmaceutical company offering a comprehensive portfolio of animal health products across four segments: Industrial Poultry (vaccines, disinfectants, parasiticides, anticoccidials, anti-infectives), Traditional/Village Poultry (ITA-NEW Newcastle disease vaccine and V.P.V. dewormer), Ruminants (trypanocidals SECURIDIUM and SURVIDIM, external parasiticides CYPERTOP, internal parasiticides BENZAL/BOLUMISOLE/DITROX, anti-infectives OXYCLINE/PENI-STREPTO/VETOSPRAY), and Pets (vaccines, antiparasitics, nutritional complements, insecticidal shampoo). Products are manufactured in European GMP-certified facilities with AVI (live vaccines) and ITA (inactivated vaccines) designations for poultry, and distributed to over 40 countries across 5 geographical zones.

Differentiator

Problem solved

Functional benefit

Brands

• AVI: Product line designation for live vaccines for poultry (Newcastle, Gumboro, Avian Infectious Bronchitis, Fowl Pox, Infectious Coryza, Egg Drop Syndrome).
• ITA
• SECURIDIUM
• SURVIDIM
• CYPERTOP
• OXYCLINE 20%
• PENI-STREPTO
• VETOSPRAY
• BENZAL
• BOLUMISOLE
• DITROX
• LEVALAP
• LEVASOL
• ANTICOX
• AMPROLIUM 20%
• DICLACOX

Products and services

• AVI Live Vaccines (Industrial Poultry) Range of live vaccines for poultry protecting against Newcastle disease, Gumboro disease, avian infectious bronchitis, Fowl Pox, infectious Coryza, and Egg Drop Syndrome Virus (EDS), used in industrial poultry vaccination programs.
• ITA Inactivated Vaccines (Industrial Poultry) Range of inactivated poultry vaccines including polyvalent combinations, manufactured in a certified GMP production site respecting European standards, used in industrial poultry vaccination programs.
• ITA-NEW (ND) Village Poultry Vaccine Inactivated vaccine against Newcastle disease for village poultry, packaged in 100-dose PET vials adapted to small-scale farms; developed with international development-organization support and used for decades in Sub-Saharan Africa.
• Industrial Poultry Disinfectants Complete prevention program with complementary disinfectants tested for efficiency against the most resistant germs in the poultry industry, used for biosecurity and pathogen-pressure reduction.
• LEVALAP Industrial Poultry Internal Parasiticide Internal parasiticide for industrial poultry targeting intestinal parasites, supplied in farm-friendly packaging.
• LEVASOL Industrial Poultry Internal Parasiticide Internal parasiticide for industrial poultry with easy-to-use packaging for administration on farms.
• ANTICOX Anticoccidial for Poultry Anticoccidial drug for treating coccidiosis in poultry, used as part of a rotation program to prevent resistance emergence.
• AMPROLIUM 20% Anticoccidial for Poultry Anticoccidial drug for treating coccidiosis in poultry, addressing a condition with significant economic impact in poultry farming.
• DICLACOX Anticoccidial for Poultry Anticoccidial drug for poultry used in rotation programs to limit resistance development.
• Industrial Poultry Anti-Infectives Poultry anti-infective products combined with specific excipients and presented in powder form for complete solubility in drinking water, enabling quick and efficient treatment of major poultry diseases.
• SECURIDIUM Ruminant Trypanocide Trypanocidal drug containing isometamidium chloride combined with antipyrine in fine granular form, used as a reference preventive treatment for trypanosomosis and manufactured in a GMP-certified European facility.
• SURVIDIM Ruminant Trypanocide Unique diminazene diaceturate formulation combined with antipyrine and vitamins B12 and B6 for treatment of trypanosomosis, supporting quick recovery by increasing hematocrit and weight gain.
• CYPERTOP Ruminant External Parasiticide External parasiticide with miticide and insecticide activity based on cypermethrin, chlorpyriphos, piperonyl butoxide and lemongrass; proven efficacy against Boophilus microplus ticks and complements tsetse fly control programs.
• BENZAL Ruminant Internal Parasiticide Internal parasiticide for ruminants, recognized as a reference product by farmers for regular deworming programs.
• BOLUMISOLE Ruminant Internal Parasiticide Internal parasiticide for ruminants, recognized as a reference product by farmers for deworming programs.
• DITROX Ruminant Internal Parasiticide Internal parasiticide for ruminants, recognized as a reference product by farmers for regular deworming.
• OXYCLINE 20% Ruminant Anti-Infective Anti-infective for ruminants in injectable form, part of Laprovet's complete range for fighting bacterial diseases.
• PENI-STREPTO Ruminant Anti-Infective Anti-infective for ruminants used for fighting bacterial diseases, part of Laprovet's key product portfolio.
• VETOSPRAY Ruminant Anti-Infective Spray Anti-infective spray for ruminants, used as part of Laprovet's complete range for fighting bacterial diseases.
• Pet Vaccines (Dogs and Cats) Specialized vaccines for dogs and cats designed to protect against major companion-animal diseases.
• Pet Antiparasitic Tablets Antiparasitic tablets for dogs and cats to control internal and external parasites.
• Pet Nutritional Complements Nutritional supplements for dogs and cats to support overall health and wellbeing.
• Pet Insecticidal Shampoo Insecticidal shampoo for dogs and cats to protect against external parasites.
• V.P.V. (Vermifuge Polyvalent Volailles) Polyvalent Dewormer Polyvalent dewormer for village poultry in tablet form; complements the ITA-NEW Newcastle disease vaccine by improving the quality of vaccination intake when used together.

Quantifiable outcome

• 24 million poultry vaccinated in 2017 in Burkina Faso project, achieving best vaccination coverage ever reached in the area
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature3 records

Partnerships

Four partnerships are on record, tiered core and minor.

• CPAVI (Centre de Promotion de l'Aviculture Villageoise)coreStrategic or Co-development Partner · 1 January 2016Partnership with public sector in Burkina Faso for training of vaccinators, provision of equipment, and distribution of Newcastle disease vaccine and dewormers for village poultry farmers. Part of broader village aviculture support project.
• VSF (Vétérinaires sans Frontières)coreStrategic or Co-development Partner · 1 January 2016Collaboration with VSF for implantation of private technicians in West African subregion to improve health coverage of village poultry. Joint initiative for disease prevention in rural poultry farming.
• UEMOA (Union Economique et Monétaire de l'Afrique de l'Ouest)coreStrategic or Co-development PartnerCollaboration since 2010 implementation of Community Regulations governing veterinary drugs. LAPROVET holds 36 Community Marketing Authorizations, the largest number among veterinary companies in the UEMOA zone (Benin, Burkina Faso, Côte d'Ivoire, Togo, Guinea-Bissau, Mali, Senegal, Niger).
• International Development OrganisationsminorStrategic or Co-development PartnerSupport for development of village poultry vaccination programs, including development of ITA-NEW (ND) vaccine and training programs in Sahel region. Programs successfully used for many decades in Sub-Saharan Africa.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Virbac: French global animal-health company specializing in vaccines, parasiticides, and pharmaceuticals across livestock, pets, and aquaculture. Comparable to Laprovet as a French veterinary pharmaceutical peer with similar product categories, though substantially larger and more diversified.
• Zoetis: World's largest standalone animal-health company offering vaccines, parasiticides, anti-infectives, and diagnostics across all major species. Comparable to Laprovet's product categories across poultry and ruminants, though vastly larger and globally diversified.
• Phibro Animal Health: US-listed global animal-health and nutrition company with strong presence in poultry, swine, and cattle vaccines, parasiticides, and nutritional specialties. Comparable to Laprovet's livestock pharmaceutical range and developing-market focus.
• Vetoquinol: French independent animal-health pharmaceutical company with broader species coverage (livestock, pets, horses). Comparable to Laprovet via shared French origin and veterinary pharmaceutical focus, though operating at significantly larger scale and broader portfolio scope.
• Boehringer Ingelheim Animal Health: One of the largest global animal-health companies, offering poultry and livestock vaccines, parasiticides, and pharmaceuticals. Comparable to Laprovet in core product categories (avian vaccines, anti-infectives) but operating at vastly larger scale and global breadth.

Direct peers

• Ceva Santé Animale: French-headquartered global animal-health company with a leading poultry vaccines portfolio (Cevac, Transmune) and strong emerging-market presence. Closely comparable to Laprovet given the shared French origin, poultry vaccine focus, and distribution reach into Africa, Asia, and the Middle East.
• Hester Biosciences: India-based animal health company focused on poultry vaccines and health products for emerging markets, including live and inactivated vaccines for Newcastle and other avian diseases. Comparable to Laprovet's poultry vaccine portfolio and developing-market GTM approach.
• HIPRA: Spanish veterinary pharmaceutical company specializing in animal vaccines and health products, with a strong poultry vaccine portfolio and significant emerging-market export activity. Comparable to Laprovet as a mid-sized European veterinary vaccine specialist.
• Indian Immunologicals: Indian veterinary biologics manufacturer producing livestock and poultry vaccines (Newcastle disease, Gumboro, FMD) targeted at developing markets. Comparable to Laprovet as a regional vaccine specialist serving smallholder and emerging-market livestock farmers.
• Bioveta: Czech veterinary biologics manufacturer with poultry and livestock vaccine ranges exported internationally. Comparable to Laprovet as a mid-sized European-headquartered veterinary vaccine manufacturer with international distribution.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/laprovet
• Facebookfacebook.com/laprovet
• LinkedInlinkedin.com/company/laprovet

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laprovet